According to Transparency Market Research’s latest report on the global pharmaceutical glass ampoules market for the historical period of 2014-2018 and forecast period of 2019-2027, the pharmaceutical glass ampoules market is anticipated to be driven by availability of compact and cost-effective pharmaceutical products. The global pharmaceutical glass ampoules market was valued at ~US$ 2 Bn in 2018, and is expected to expand at a CAGR of 7.5% during the forecast period. Increasing consumption of medicines, vaccines, and insulin is also driving the pharmaceutical glass ampoules market. Moreover, safe and bacteria-free drug storage system is leading to high adoption of glass ampoules.
Key Players Focus on Reducing the Counterfeiting of Pharmaceutical Products
- Counterfeiting of drugs is one of the major problems faced in the pharmaceuticals industry. This results in economic loss of legal companies and poor health of drug consumers. Nearly one-sixth of the total turnovers of branded companies is affected by instances of counterfeiting. These drugs are either adulterated or spurious. For instance, Schott AG developed anti-counterfeit pharmaceutical glass ampoule called ampoules AC. This helps in protecting intellectual property and ensuring patients’ safety by enriching standard ink with light emitting particles. These ampoules are available in B, C, and D forms, with capacities ranging from 1 ml to 30 ml.
- Glass ampoules are available in various formats such as straight stem, open funnel, closed funnel, double tip, and marzocchi. These ampoules are applicable for single-time storage and usage of medicines. Pharmaceutical glass ampoules are tamper-proof, which helps in preventing the possibilities of viral and bacterial infections.
Request a sample to get extensive insights into the Pharmaceutical Glass Ampoules Market
China and India to Witness Penetration with High Production Capabilities
- TMR team analysed top five leading countries (the U.S., China, Germany, the U.K., and India) in the global pharmaceutical glass ampoules market report, which generated prominent market share of countries in 2018. It is anticipated that the U.S. is the leading market for glass ampoules.
- In order to cater to the increasing demand for glass ampoules as a primary packaging solution, the U.S. imported nearly 2,000 tons of glass ampoules in 2018.
- Key players are emphasizing on business development, owing to the growth of the pharmaceuticals industry in the Asia Pacific region. Furthermore, availability of resources and cost-effectiveness in manufacturing glass ampoules provide opportunities for key players to invest in the Asia Pacific region.
- In August 2018, Gerresheimer AG initiated a plant in China and two plants in India for the manufacturing of premium quality glass containers for the pharmaceuticals industry
- In June 2019, SCHOTT AG increased the production capacity of glass tubes in India, with an investment of nearly US$ 300 Mn.
Request For COVID-19 Impact Analysis Across Industries -
Increase in Investments by Major Players for Acquisition and Business Expansion
- Manufacturers are adopting the strategy of mergers & acquisitions to increase their global footprint. Moreover, companies are focusing on increasing their customer base by developing their distribution network and increasing their geographical presence. Several key players are manufacturing pharmaceutical glass ampoules as per the Food and Drug Association (FDA), European Pharmacopeia (Ph Eur), United States Pharmacopeial Convention (USP), and Japanese Pharmacopoeia (JP) guidelines.
- Nipro PharmaPackaging International is planning to expand its business in China. Based on Healthy China 2030 activities, the healthcare industry in China is expected to grow.
0 comments:
Post a Comment